{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:32Z","timestamp":1793121512728,"version":"4.5.0"},"reference-count":288,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background\/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is rapidly becoming the most prevalent form of chronic liver disease in both pediatric and adult populations. It encompasses a wide spectrum of liver abnormalities, ranging from simple fat accumulation to severe conditions such as inflammation, fibrosis, cirrhosis, and liver cancer. Major risk factors for MASLD include obesity, insulin resistance, type 2 diabetes, and hypertriglyceridemia. Methods: This narrative review employed a comprehensive search of recent literature to identify the latest studies on the relationship between MAFLD and obesity, the health consequences and the latest treatment options to prevent long-term damage to the liver and other organs. Additionally, the article presents perspectives on diagnostic biomarkers. Results: Childhood obesity is linked to a multitude of comorbid conditions and remains a primary risk factor for adult obesity. This abnormal fat accumulation is known to have long-term detrimental effects into adulthood. Scientific evidence unequivocally demonstrates the role of obesity-related conditions, such as insulin resistance, dyslipidemia, and hyperglycemia, in the development and progression of MASLD. Oxidative stress, stemming from mitochondrial dysfunction, is a leading factor in MASLD. This review discusses the interconnections between oxidative stress, obesity, dyslipidemia, and MASLD. Conclusions: Atherogenic dyslipidemia, oxidative stress, inflammation, insulin resistance, endothelial dysfunction, and cytokines collectively contribute to the development of MASLD. Potential treatment targets for MASLD are focused on prevention and the use of drugs to address obesity and elevated blood lipid levels.<\/jats:p>","DOI":"10.3390\/metabo15050287","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:04:50Z","timestamp":1745467490000},"page":"287","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood"],"prefix":"10.3390","volume":"15","author":[{"given":"Siham","family":"Accacha","sequence":"first","affiliation":[{"name":"Department of Pediatrics, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Barillas-Cerritos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-2183","authenticated-orcid":false,"given":"Ankita","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Drewes","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Gulkarov","sequence":"additional","affiliation":[{"name":"Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"De Leon","sequence":"additional","affiliation":[{"name":"Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-2441","authenticated-orcid":false,"given":"Allison B.","family":"Reiss","sequence":"additional","affiliation":[{"name":"Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"},{"name":"Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/met.2020.0076","article-title":"Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter?","volume":"18","author":"Serbis","year":"2020","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, P., and Weiskirchen, R. (2024). The Role of Obesity in Type 2 Diabetes Mellitus\u2014An Overview. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031882"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MOP.0000000000001151","article-title":"Insulin resistance in children","volume":"34","author":"Mainieri","year":"2022","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-023-00435-4","article-title":"Child and adolescent obesity","volume":"9","author":"Lister","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cgh.2022.05.028","article-title":"Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease","volume":"21","author":"Newton","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","author":"Alexopoulos","year":"2021","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"bvab155","DOI":"10.1210\/jendso\/bvab155","article-title":"Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care","volume":"5","author":"Alexopoulos","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3892\/etm.2020.9320","article-title":"Prediction of NAFLD occurrence in prediabetes patients","volume":"20","author":"Vesa","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Radu, F., Potcovaru, C.-G., Salmen, T., Filip, P.V., Pop, C., and Fierbin\u021beanu-Braticievici, C. (2023). The Link between NAFLD and Metabolic Syndrome. Diagnostics, 13.","DOI":"10.3390\/diagnostics13040614"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lian, C.Y., Zhai, Z.Z., Li, Z.F., and Wang, L. (2020). High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem. Biol. Interact., 330.","DOI":"10.1016\/j.cbi.2020.109199"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Overi, D., Carpino, G., Franchitto, A., Onori, P., and Gaudio, E. (2020). Hepatocyte injury and hepatic stem cell niche in the progression of non-alcoholic steatohepatitis. Cells, 9.","DOI":"10.3390\/cells9030590"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","article-title":"Fibrosis and adipose tissue dysfunction","volume":"18","author":"Sun","year":"2013","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1136\/gutjnl-2019-319745","article-title":"Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease","volume":"69","author":"Silva","year":"2020","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cmet.2017.04.032","article-title":"Gut-Brain Glucose Signaling in Energy Homeostasis","volume":"25","author":"Soty","year":"2017","journal-title":"Cell Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14625","article-title":"Childhood obesity: A review of current and future management options","volume":"96","author":"Apperley","year":"2022","journal-title":"Clin. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: Epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_19","unstructured":"World Obesity Federation (2024, January 08). Atlas of Childhood Obesity. Available online: https:\/\/s3-eu-west-1.amazonaws.com\/wof-files\/11996_Childhood_Obesity_Atlas_Report_ART_V2.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamapediatrics.2024.1576","article-title":"Global Prevalence of Overweight and Obesity in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"178","author":"Zhang","year":"2024","journal-title":"JAMA Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Di Cesare, M., Sori\u0107, M., Bovet, P., Miranda, J.J., Bhutta, Z., Stevens, G.A., Laxmaiah, A., Kengne, A.P., and Bentham, J. (2019). The epidemiological burden of obesity in childhood: A worldwide epidemic requiring urgent action. BMC Med., 17.","DOI":"10.1186\/s12916-019-1449-8"},{"key":"ref_22","first-page":"e72150","article-title":"Demographic and Socioeconomic Disparities in Adolescent Obesity: Insights From the National Survey of Children\u2019s Health Database","volume":"16","author":"Arubuolawe","year":"2024","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/ijem.ijem_365_23","article-title":"Systematic Review on Prevalence of Overweight and Obesity among School Children and Adolescents in Indian Population","volume":"28","author":"Sharma","year":"2024","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000500436","article-title":"Prevalence of Severe Obesity among Primary School Children in 21 European Countries","volume":"12","author":"Spinelli","year":"2019","journal-title":"Obes. Facts."},{"key":"ref_25","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet, 390, 2627\u20132642."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pop, T.L., Maniu, D., Rajka, D., Lazea, C., Cismaru, G., \u015etef, A., and C\u0103inap, S.S. (2021). Prevalence of Underweight, Overweight and Obesity in School-Aged Children in the Urban Area of the Northwestern Part of Romania. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18105176"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e20173459","DOI":"10.1542\/peds.2017-3459","article-title":"Prevalence of Obesity and Severe Obesity in US Children, 1999\u20132016","volume":"141","author":"Skinner","year":"2018","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e20170865","DOI":"10.1542\/peds.2017-0865","article-title":"Racial and Ethnic Disparities in Early Childhood Obesity","volume":"141","author":"Isong","year":"2018","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9224425","DOI":"10.1155\/2024\/9224425","article-title":"Behavioral Determinants of Childhood Obesity in the United States: An Exploratory Study","volume":"2024","author":"Palit","year":"2024","journal-title":"J. Obes."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dubois, L., Ohm Kyvik, K., Girard, M., Fabiola Tatone-Tokuda, F., P\u00e9russe, D., Hjelmborg, J., Skytthe, A., Rasmussen, F., Wright, M.J., and Lichtenstein, P. (2012). Genetic and environmental contributions to weight, height, and BMI from birth to 19\u2009years of age: An international study of over 12,000 twin pairs. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0030153"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/chi.2024.0243","article-title":"A Latent Class Analysis of Family Eating Behaviors and Home Environment Habits on Preschool-Aged Children\u2019s Body Mass Index","volume":"20","author":"Carroll","year":"2024","journal-title":"Child. Obes."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.11124\/JBISRIR-2017-003695","article-title":"Effectiveness of family-based weight management interventions for children with overweight and obesity: An umbrella review","volume":"17","author":"Chai","year":"2019","journal-title":"JBI Database Syst. Rev. Implement. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5114\/pedm.2024.142586","article-title":"Children\u2019s behaviour and childhood obesity. Zachowanie dzieci a oty\u0142o\u015b\u0107 dzieci\u0119ca","volume":"30","author":"Ali","year":"2024","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mayocp.2016.09.017","article-title":"Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment","volume":"92","author":"Kumar","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jped.2023.09.011","article-title":"What causes obesity in children and adolescents?","volume":"100","author":"Weffort","year":"2024","journal-title":"J. Pediatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jand.2015.05.020","article-title":"Sugar-Sweetened Beverages and Obesity Risk in Children and Adolescents: A Systematic Analysis on How Methodological Quality May Influence Conclusions","volume":"116","author":"Keller","year":"2016","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Monzani, A., Ricotti, R., Caputo, M., Solito, A., Archero, F., Bellone, S., and Prodam, F. (2019). A Systematic Review of the Association of Skipping Breakfast with Weight and Cardiometabolic Risk Factors in Children and Adolescents. What Should We Better Investigate in the Future?. Nutrients, 11.","DOI":"10.3390\/nu11020387"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pi\u0105tkowska-Chmiel, I., Krawiec, P., Zi\u0119tara, K.J., Paw\u0142owski, P., Samardakiewicz, M., Pac-Ko\u017cuchowska, E., and Herbetet, M. (2023). The Impact of Chronic Stress Related to COVID-19 on Eating Behaviors and the Risk of Obesity in Children and Adolescents. Nutrients, 16.","DOI":"10.3390\/nu16010054"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S1368980017001331","article-title":"Consumption of ultra-processed foods and body fat during childhood and adolescence: A systematic review","volume":"21","author":"Costa","year":"2018","journal-title":"Public Health Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ajcnut.2024.07.024","article-title":"Ultraprocessed food intake and body mass index change among youths: A prospective cohort study","volume":"120","author":"Du","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1089\/chi.2014.0117","article-title":"Sugar-Sweetened Beverages and Obesity among Children and Adolescents: A Review of Systematic Literature Reviews","volume":"11","author":"Keller","year":"2015","journal-title":"Child. Obes."},{"key":"ref_42","first-page":"e079234","article-title":"Intake of sugar sweetened beverages among children and adolescents in 185 countries between 1990 and 2018: Population based study","volume":"386","author":"Micha","year":"2024","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1161\/CIR.0000000000000591","article-title":"Sedentary Behaviors in Today\u2019s Youth: Approaches to the Prevention and Management of Childhood Obesity: A Scientific Statement From the American Heart Association","volume":"138","author":"Barnett","year":"2018","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Byun, D., Kim, Y., Jang, H., and Oh, H. (2024). Screen time and obesity prevalence in adolescents: An isotemporal substitution analysis. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-20639-x"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.acap.2024.10.010","article-title":"Food and housing insecurity, COVID-19 pandemic effects on health-related activities, and care plans for children with obesity","volume":"25","author":"Egan","year":"2024","journal-title":"Acad. Pediatr."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chang, T.H., Chen, Y.C., Chen, W.Y., Chen, C.Y., Hsu, W.Y., Chou, Y., and Chang, Y.H. (2021). Weight gain associated with COVID-19 lockdown in children and adolescents: A systematic review and meta-analysis. Nutrients, 13.","DOI":"10.3390\/nu13103668"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e2021050123","DOI":"10.1542\/peds.2021-050123","article-title":"COVID-19 and Changes in Child Obesity","volume":"147","author":"Jenssen","year":"2021","journal-title":"Pediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ruiz-Roso, M.B., de Carvalho Padilha, P., Mantilla-Escalante, D.C., Ulloa, N., Brun, P., Acevedo-Correa, D., Arantes Ferreira Peres, W., Martorell, M., Aires, M.T., and de Oliveira Cardoso, L. (2020). COVID-19 Confinement and Changes of Adolescent\u2019s Dietary Trends in Italy, Spain, Chile, Colombia and Brazil. Nutrients, 12.","DOI":"10.3390\/nu12061807"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/oby.22861","article-title":"Effects of COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study","volume":"28","author":"Pietrobelli","year":"2020","journal-title":"Obesity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5114\/pedm.2024.144042","article-title":"Obesity in children: Inheritance and treatment-state of art 2024","volume":"30","author":"Zachurzok","year":"2024","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e00405","DOI":"10.1016\/j.plabm.2024.e00405","article-title":"A genetic condition that spans both extremes of the nutritional spectrum","volume":"40","author":"Johnson","year":"2024","journal-title":"Pract. Lab. Med."},{"key":"ref_52","first-page":"e37866","article-title":"The Diagnosis and Genetic Mechanisms of Prader-Willi Syndrome: Findings From a Moroccan Population Study","volume":"15","author":"Ahakoud","year":"2023","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.pcl.2024.06.001","article-title":"The Genetics of Obesity","volume":"71","author":"Siddiqui","year":"2024","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/phar.4626","article-title":"Precision medicine to identify, prevent, and treat pediatric obesity","volume":"44","author":"Tillman","year":"2024","journal-title":"Pharmacotherapy"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pcl.2024.06.003","article-title":"Overview of Pediatric Obesity as a Disease","volume":"71","author":"Waldrop","year":"2024","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21037\/tp.2017.10.02","article-title":"Metabolic syndrome in children and adolescents","volume":"6","author":"Raman","year":"2017","journal-title":"Transl. Pediatr."},{"key":"ref_57","first-page":"25","article-title":"Continuous metabolic syndrome score in cardiovascular risk assessment in adolescents","volume":"32","author":"Dorko","year":"2025","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3390\/jcm14072341","article-title":"The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity","volume":"14","author":"Bondesan","year":"2025","journal-title":"J. Clin. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gepstein, V., and Weiss, R. (2019). Obesity as the Main Risk Factor for Metabolic Syndrome in Children. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00568"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Yang, K., and Song, M. (2023). New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut-Liver-Heart Crosstalk. Nutrients, 15.","DOI":"10.3390\/nu15183970"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1507\/endocrj.EJ24-0192","article-title":"Physiological and pathophysiological actions of insulin in the liver","volume":"72","author":"Kubota","year":"2025","journal-title":"Endocr. J."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Fujii, H., Kawada, N., and Japan Study Group Of Nafld Jsg-Nafld (2020). The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113863"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/a-2266-1503","article-title":"The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases","volume":"56","author":"Li","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Szukiewicz, D. (2023). Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1026.v1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-031-63657-8_10","article-title":"Reappraisal of Adipose Tissue Inflammation in Obesity","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Calcaterra, V., Regalbuto, C., Porri, D., Mazzon, E., Vinci, F., Zuccotti, G., Fabiano, V., and Cena, H. (2020). Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. Biomolecules, 10.","DOI":"10.3390\/biom10091324"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kojta, I., Chaci\u0144ska, M., and B\u0142achnio-Zabielska, A. (2020). Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients, 12.","DOI":"10.3390\/nu12051305"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mo, Y.Y., Han, Y.X., Xu, S.N., Jiang, H.L., Wu, H.X., Cai, J.M., Li, L., Bu, Y.H., Xiao, F., and Liang, H.D. (2024). Adipose Tissue Plasticity: A Comprehensive Definition and Multidimensional Insight. Biomolecules, 14.","DOI":"10.3390\/biom14101223"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"101143","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhang, C., Zheng, M., Bai, R., Chen, J., Yang, H., and Luo, G. (2024). Molecular mechanisms of lipid droplets-mitochondria coupling in obesity and metabolic syndrome: Insights and pharmacological implications. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1491815"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/archdischild-2019-318063","article-title":"Non-alcoholic fatty liver disease and childhood obesity","volume":"106","author":"Shaunak","year":"2021","journal-title":"Arch. Dis. Child."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI88882","article-title":"The initiation of metabolic inflammation in childhood obesity","volume":"127","author":"Singer","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2414796","DOI":"10.1080\/19490976.2024.2414796","article-title":"The effects of gut microbiota on appetite regulation and the underlying mechanisms","volume":"16","author":"Yu","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Howick, K., Griffin, B.T., Cryan, J.F., and Schellekens, H. (2017). From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020273"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"115401","DOI":"10.1016\/j.bbr.2024.115401","article-title":"Exploring the genetic contribution in obesity: An overview of dopaminergic system genes","volume":"480","author":"Silva","year":"2025","journal-title":"Behav. Brain Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"(2025). Lipid signatures of cardiometabolic risk in children and adolescents with obesity. Nat. Med., 31, 43\u201344.","DOI":"10.1038\/s41591-024-03399-4"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12968-017-0401-3","article-title":"Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children","volume":"19","author":"Jing","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1017\/S1047951124025472","article-title":"Subclinical left ventricular structural and functional alterations in children with obesity: Is body mass or insulin resistance the main issue?","volume":"34","author":"Civilibal","year":"2024","journal-title":"Cardiol. Young"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jpeds.2010.10.016","article-title":"Cardiovascular impact of the pediatric obesity epidemic: Higher left ventricular mass is related to higher body mass index","volume":"158","author":"Crowley","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Fazio, S., Bellavite, P., and Affuso, F. (2024). Chronically Increased Levels of Circulating Insulin Secondary to Insulin Resistance: A Silent Killer. Biomedicines, 12.","DOI":"10.20944\/preprints202409.1125.v1"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Pastore, I., Bolla, A.M., Montefusco, L., Lunati, M.E., Rossi, A., Assi, E., Zuccotti, G.V., and Fiorina, P. (2020). The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144928"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer","year":"2010","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ding, H., Zhang, J., Zhang, F., Zhang, S., Chen, X., Liang, W., and Xie, Q. (2021). Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.741764"},{"key":"ref_87","first-page":"e58714","article-title":"Obstructive Sleep Apnea Among Obese Children in Tabuk City, Saudi Arabia","volume":"16","author":"AlBishi","year":"2024","journal-title":"Cureus"},{"key":"ref_88","first-page":"933","article-title":"Clinical features of obstructive sleep apnea in children with obesity","volume":"23","author":"Liu","year":"2021","journal-title":"Chin. J. Contemp. Pediatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"106658","DOI":"10.1016\/j.phrs.2023.106658","article-title":"Pediatric obesity and severe asthma: Targeting pathways driving inflammation","volume":"188","author":"Ghezzi","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Rinonapoli, G., Pace, V., Ruggiero, C., Ceccarini, P., Bisaccia, M., Meccariello, L., and Caraffa, A. (2021). Obesity and bone: A complex relationship. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413662"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lotan, R., Thein, R., Gordon, B., Tenenbaum, S., Derazne, E., Tzur, D., Afek, A., and Hershkovich, O. (2023). Is There an Association between BMI, Height, and Gender and Long-Bone Fractures during Childhood and Adolescence? A Large Cross-Sectional Population Study of 911,206 Subjects. Children, 10.","DOI":"10.3390\/children10060984"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e20181067","DOI":"10.1542\/peds.2018-1067","article-title":"Childhood Obesity and Slipped Capital Femoral Epiphysis","volume":"142","author":"Perry","year":"2018","journal-title":"Pediatrics"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Farella, I., Chiarito, M., Vitale, R., D\u2019Amato, G., and Faienza, M.F. (2025). The \u201cBurden\u201d of Childhood Obesity on Bone Health: A Look at Prevention and Treatment. Nutrients, 17.","DOI":"10.3390\/nu17030491"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10620-022-07563-z","article-title":"Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children","volume":"68","author":"Khan","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2019.08.008","article-title":"A polygenic score for body mass index is associated with depressive symptoms via early life stress: Evidence for gene-environment correlation","volume":"118","author":"Avinun","year":"2019","journal-title":"J. Psychiatr.Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1573396318666220429085231","article-title":"Acanthosis Nigricans: An Updated Review","volume":"19","author":"Leung","year":"2022","journal-title":"Curr. Pediatr. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13052-024-01722-w","article-title":"The relationship between body mass index and cerebrospinal fluid pressure in children with pseudotumor cerebri","volume":"50","author":"Kaytan","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lemieux, I., and Despr\u00e9s, J.P. (2020). Metabolic Syndrome: Past, Present and Future. Nutrients, 12.","DOI":"10.3390\/nu12113501"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00431-024-05848-1","article-title":"Pediatric MASLD: Current understanding and practical approach","volume":"184","author":"Stroes","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/apt.17846","article-title":"Implications of the new nomenclature of steatotic liver disease and defi-nition of metabolic dysfunction-associated steatotic liver disease","volume":"59","author":"Loomba","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroen-terology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.revmed.2023.10.438","article-title":"Diagnostic et \u00e9valuation de l\u2019h\u00e9patopathie st\u00e9atosique m\u00e9tabolique","volume":"45","author":"Canivet","year":"2024","journal-title":"Rev. M\u00e9d. Interne"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jpeds.2004.06.044","article-title":"Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents","volume":"145","author":"Redden","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/j.1536-4801.2006.tb00012.x","article-title":"Relationship of Hepatic Steatosis to Adipose Tissue Distribution in Pediatric Nonalcoholic Fatty Liver Disease","volume":"42","author":"Fishbein","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41390-024-03112-8","article-title":"Waist-circumference-to-height-ratio had better longitudinal agreement with DEXA-measured fat mass than BMI in 7237 children","volume":"96","author":"Agbaje","year":"2024","journal-title":"Pediatr. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.medj.2024.03.017","article-title":"An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Zhang","year":"2024","journal-title":"Med"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: New genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.cmet.2021.09.010","article-title":"Molecular aspects of fructose metabolism and metabolic disease","volume":"33","author":"Herman","year":"2021","journal-title":"Cell Metab."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Jegatheesan, P., and De Bandt, J.P. (2017). Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism. Nutrients, 9.","DOI":"10.3390\/nu9030230"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jhep.2014.04.018","article-title":"Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: The ALSPAC study","volume":"61","author":"Anderson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12688\/wellcomeopenres.15132.1","article-title":"The Avon Longitudinal Study of Parents and Children (ALSPAC): An update on the enrolled sample of index children in 2019","volume":"4","author":"Northstone","year":"2019","journal-title":"Wellcome Open Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cld.2013.09.009","article-title":"The role of diet and nutritional intervention in managing patients with NAFLD","volume":"18","author":"Barrera","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"155552","DOI":"10.1016\/j.metabol.2023.155552","article-title":"Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity","volume":"144","author":"Papadopoulos","year":"2023","journal-title":"Metabolism"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.14910","article-title":"Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: Beyond traditional metabolic factors","volume":"48","author":"Tovoli","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Wang, Z., Tan, W., Huang, J., Li, Q., Wang, J., Su, H., Guo, C., and Liu, H. (2024). Small intestinal bacterial overgrowth and metabolic dysfunction-associated steatotic liver disease. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1502151"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Valvano, M., Longo, S., Stefanelli, G., Frieri, G., Viscido, A., and Latella, G. (2020). Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders. Nutrients, 12.","DOI":"10.3390\/nu12040940"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.32570","article-title":"Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children","volume":"77","author":"Goyal","year":"2022","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Rives, C., Fougerat, A., Ellero-Simatos, S., Loiseau, N., Guillou, H., Gamet-Payrastre, L., and Wahli, W. (2020). Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. Biomolecules, 10.","DOI":"10.3390\/biom10121702"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Zarkovic, N. (2020). Roles and Functions of ROS and RNS in Cellular Physiology and Pathology. Cells, 9.","DOI":"10.3390\/cells9030767"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6175804","DOI":"10.1155\/2019\/6175804","article-title":"ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells","volume":"2019","author":"Snezhkina","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4274\/Jcrpe.825","article-title":"Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease","volume":"5","author":"Pirgon","year":"2013","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e23466","DOI":"10.1096\/fj.202302447R","article-title":"Oxidative stress in metabolic dysfunction-associated steatotic liver disease (MASLD): How does the animal model resemble human disease?","volume":"38","author":"Jakubek","year":"2024","journal-title":"FASEB J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jceh.2012.10.009","article-title":"Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis","volume":"3","author":"Kumar","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_133","first-page":"1165","article-title":"Serum glutathione peroxidase is associated with nonalcoholic fatty liver disease in children and adolescents. La glutati\u00f3n-peroxidasa s\u00e9rica se asocia a la enfermedad del h\u00edgado graso no alcoh\u00f3lico en ni\u00f1os y adolescentes","volume":"41","author":"Santos","year":"2024","journal-title":"Nutr. Hosp."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Mandala, A., Janssen, R.C., Palle, S., Short, K.R., and Friedman, J.E. (2020). Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients, 12.","DOI":"10.3390\/nu12103166"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"111541","DOI":"10.1016\/j.nut.2021.111541","article-title":"Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease","volume":"94","author":"Kopiczko","year":"2022","journal-title":"Nutrition"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhao, Y., Xu, C., Hong, Y., Lu, H., Wu, J., and Chen, Y. (2014). Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study. Sci. Rep., 4.","DOI":"10.1038\/srep05832"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.3390\/nu6114691","article-title":"Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions","volume":"6","author":"Yang","year":"2014","journal-title":"Nutrients"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ars.2018.7704","article-title":"The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?","volume":"31","author":"Nobili","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Negri, R., Trinchese, G., Carbone, F., Caprio, M.G., Stanzione, G., di Scala, C., Micillo, T., Perna, F., Tarotto, L., and Gelzo, M. (2020). Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD). J. Clin. Med., 9.","DOI":"10.3390\/jcm9010141"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-alcoholic fatty liver disease severity and metabolic complications in obese children: Impact of omega-3 fatty acids","volume":"58","author":"Spahis","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Gong, J., Tu, W., Liu, J., and Tian, D. (2023). Hepatocytes: A key role in liver inflammation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1083780"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: A membrane trafficking machine","volume":"218","author":"Schulze","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_143","first-page":"67","article-title":"Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury","volume":"13","author":"Baeck","year":"2014","journal-title":"EXCLI J."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Allameh, A., Niayesh-Mehr, R., Aliarab, A., Sebastiani, G., and Pantopoulos, K. (2023). Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12091653"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: A key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3748\/wjg.v20.i9.2136","article-title":"Role of mitochondria in alcoholic liver disease","volume":"20","author":"Nassir","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.23671","article-title":"Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection","volume":"52","author":"Seronello","year":"2010","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/hep.24279","article-title":"The contribution of endoplasmic reticulum stress to liver diseases","volume":"53","author":"Dara","year":"2011","journal-title":"Hepatology"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Niranjan, S., Phillips, B.E., and Giannoukakis, N. (2023). Uncoupling hepatic insulin resistance-hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1193373"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Michalak","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Arroyave-Ospina, J.C., Wu, Z., Geng, Y., and Moshage, H. (2021). Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy. Antioxidants, 10.","DOI":"10.3390\/antiox10020174"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Ma, Y., Lee, G., Heo, S.-Y., and Roh, Y.-S. (2022). Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11010091"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11745-016-4160-y","article-title":"Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPAR\u03b1 and SREBP-1c in L-02 Cells","volume":"51","author":"Qin","year":"2016","journal-title":"Lipids"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Ramanathan, R., Ali, A.H., and Ibdah, J.A. (2022). Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137280"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Tang, S., Geng, Y., and Lin, Q. (2024). The role of mitophagy in metabolic diseases and its exercise intervention. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1339128"},{"key":"ref_159","first-page":"1","article-title":"Oxidative Stress and Hepatic Stellate Cells: A PARADOXICAL RELATIONSHIP","volume":"7","author":"Gandhi","year":"2012","journal-title":"Trends Cell. Mol. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e996","DOI":"10.1038\/cddis.2013.499","article-title":"Molecular mechanisms of hepatic apoptosis","volume":"16","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","article-title":"Apoptosis and non-alcoholic fatty liver diseases","volume":"24","author":"Kanda","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","article-title":"Targeting cell death in NAFLD: Mechanisms and targeted therapies","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Park, S.J., Garcia Diaz, J., Um, E., and Hahn, Y.S. (2023). Major roles of kupffer cells and macrophages in NAFLD development. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1150118"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","article-title":"Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease","volume":"190","author":"Slevin","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.3748\/wjg.v22.i31.6965","article-title":"Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?","volume":"22","author":"Handa","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Diehl, K.L., Vorac, J., Hofmann, K., Meiser, P., Unterweger, I., Kuerschner, L., Weighardt, H., F\u00f6rster, I., and Thiele, C. (2020). Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation. Cells, 9.","DOI":"10.3390\/cells9102258"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Ramos-Tovar, E., and Muriel, P. (2020). Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver. Antioxidants, 9.","DOI":"10.3390\/antiox9121279"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jhep.2010.09.022","article-title":"Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells","volume":"54","author":"Novo","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-022-05088-x","article-title":"Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","article-title":"Liver macrophages in health and disease","volume":"55","author":"Guilliams","year":"2022","journal-title":"Immunity"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Srinivas, A.N., Suresh, D., Santhekadur, P.K., Suvarna, D., and Kumar, D.P. (2021). Extracellular Vesicles as Inflammatory Drivers in NAFLD. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.627424"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Ye, L., He, S., Mao, X., Zhang, Y., Cai, Y., and Li, S. (2020). Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01193"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"120846","DOI":"10.1016\/j.lfs.2022.120846","article-title":"Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice","volume":"306","author":"Han","year":"2022","journal-title":"Life Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.30506","article-title":"The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcmgh.2022.06.007","article-title":"Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis","volume":"14","author":"Kaufmann","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Ramos-Tovar, E., and Muriel, P. (2023). NLRP3 inflammasome in hepatic diseases: A pharmacological target. Biochem. Pharmacol., 217.","DOI":"10.1016\/j.bcp.2023.115861"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Osman, H.A., Abuhamdah, S.M.A., Hassan, M.H., Hashim, A.A., Ahmed, A.E., Elsayed, S.S., El-Sawy, S.A., Gaber, M.A., and Abdelhady, M. (2024). NLRP3 inflammasome pathway involved in the pathogenesis of metabolic associated fatty liver disease. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-69764-y"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Shepard, C.R. (2021). TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.613639"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative Stress in Non-Alcoholic Fatty Liver Disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"de Gregorio, E., Colell, A., Morales, A., and Mar\u00ed, M. (2020). Relevance of SIRT1-NF-\u03baB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113858"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Tang, S.P., Mao, X.L., Chen, Y.H., Yan, L.L., Ye, L.P., and Li, S.W. (2022). Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.870239"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Saha, S., Buttari, B., Panieri, E., Profumo, E., and Saso, L. (2020). An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation. Molecules, 25.","DOI":"10.3390\/molecules25225474"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- \u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_190","first-page":"742931","article-title":"NADPH Oxidases in Chronic Liver Diseases","volume":"2014","author":"Jiang","year":"2014","journal-title":"Adv. Hepatol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Nasc\u00e8, A., Gariani, K., Jornayvaz, F.R., and Szanto, I. (2022). NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants, 11.","DOI":"10.3390\/antiox11061131"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"McGlinchey, A.J., Govaere, O., Geng, D., Ratzieu, V., Allison, M., Bousier, J., Petta, S., de Oliviera, C., Bugianesi, E., and Schattenberg, J.M. (2022). Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Rep., 4.","DOI":"10.1016\/j.jhepr.2022.100477"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Herranz-It\u00farbide, M., Pe\u00f1uelas-Haro, I., Espinosa-Sotelo, R., Bertran, E., and Fabregat, I. (2021). The TGF-\u03b2\/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease. Cells, 10.","DOI":"10.3390\/cells10092312"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-\u03b2 signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J."},{"key":"ref_195","first-page":"1498","article-title":"Exosomes of Whartons\u2019 jelly mesenchymal stem cell reduce the NOX genes in TGF-\u03b2-induced hepatic fibrosis","volume":"25","author":"Afarin","year":"2022","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Dewidar, B., Meyer, C., Dooley, S., and Meindl-Beinker, A.N. (2019). TGF-\u03b2 in Hepatic Stellate Cell Activation and Liver Fibrogenesis\u2014Updated 2019. Cells, 8.","DOI":"10.3390\/cells8111419"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"31","DOI":"10.61186\/ibj.4005","article-title":"Curcumin Modulates NOX Gene Expression and ROS Production via P-Smad3C in TGF-\u03b2-Activated Hepatic Stellate Cells","volume":"28","author":"Asadizade","year":"2024","journal-title":"Iran. Biomed. J."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13287-024-03852-8","article-title":"The effects of TGF-\u03b2-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells","volume":"15","author":"Wilhelmsen","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e13163","DOI":"10.1111\/ijpo.13163","article-title":"Effect of Indo-Mediterranean diet versus calorie-restricted diet in children with non-alcoholic fatty liver disease: A pilot randomized control trial","volume":"19","author":"Deshmukh","year":"2024","journal-title":"Pediatr. Obes."},{"key":"ref_202","first-page":"6997280","article-title":"Association between BMI Change, Transaminases, and Other Metabolic Parameters in Children with Nonalcoholic Fatty Liver Disease","volume":"2024","author":"Lyden","year":"2024","journal-title":"J. Obes."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s12020-024-03783-7","article-title":"Diet, exercise, and supplements: What is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?","volume":"85","author":"Serbis","year":"2024","journal-title":"Endocrine"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.obpill.2022.100031","article-title":"Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022","volume":"3","author":"Cuda","year":"2022","journal-title":"Obes. Pillars."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.cgh.2021.11.039","article-title":"Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease","volume":"20","author":"Lefere","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","article-title":"Progression of fatty liver disease in children receiving standard of care lifestyle advice","volume":"159","author":"Xanthakos","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/chi.2017.0027","article-title":"The Effects of Exercise on Abdominal Fat and Liver Enzymes in Pediatric Obesity: A Systematic Review and Meta-Analysis","volume":"13","author":"Peterson","year":"2017","journal-title":"Child. Obes."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Calcaterra, V., Magenes, V.C., Vandoni, M., Berardo, C., Marin, L., Bianchi, A., Cordaro, E., Silvestro, G.S., Silvestri, D., and Carnevale Pellino, V. (2022). Benefits of Physical Exercise as Approach to Prevention and Reversion of Non-Alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. Children, 9.","DOI":"10.3390\/children9081174"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13312-024-3290-1","article-title":"Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN)","volume":"61","author":"Sood","year":"2024","journal-title":"Indian Pediatr."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pcad.2018.01.013","article-title":"Evidence-Based Exercise Recommendations to Reduce Hepatic Fat Content in Youth- a Systematic Review and Meta-Analysis","volume":"61","author":"Medrano","year":"2018","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Trenell","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/ijpo.13067","article-title":"Review of paediatric obesity and non-alcoholic fatty liver disease-A focus on emerging non-pharmacologic treatment strategies","volume":"18","author":"Piester","year":"2023","journal-title":"Pediatr. Obes."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"15445","DOI":"10.1016\/j.metabol.2020.154455","article-title":"The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"115","author":"Koutoukidis","year":"2021","journal-title":"Metabolism"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2017.0332","article-title":"Screening for obesity and intervention for weight management in children and adolescents: Evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Evans","year":"2017","journal-title":"JAMA"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpediatrics.2009.123","article-title":"Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: A 1-year follow-up study","volume":"163","author":"Reinehr","year":"2009","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/jpet.103.064964","article-title":"Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa\/fa rats","volume":"310","author":"Yasuda","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11357-023-01059-y","article-title":"Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, \"futile\" fatty acid cycling, and FADH2 oxidation","volume":"46","author":"Abrosimov","year":"2024","journal-title":"Geroscience"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.5009\/gnl20367","article-title":"Effects of metformin on hepatic steatosis in adults with nonalcoholic fatty liver disease and diabetes: Insights from the cellular to patient levels","volume":"15","author":"Pinyopornpanish","year":"2021","journal-title":"Gut Liver."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bcp.2014.12.004","article-title":"The liver-selective NO donor, V-PYRRO\/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet","volume":"93","author":"Maslak","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mmr.2022.12922","article-title":"Role of the AMPK\/SIRT1 pathway in non-alcoholic fatty liver disease (Review)","volume":"27","author":"Anggreini","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Yasmin, T., Rahman, M.M., Khan, F., Kabir, F., Nahar, K., Lasker, S., Islam, M.D., Hossain, M.M., Hasan, R., and Rana, S. (2021). Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple and anti-inflammatory pathways. Biochem. Biophys. Rep., 28.","DOI":"10.1016\/j.bbrep.2021.101168"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43228-0","article-title":"Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine","volume":"9","author":"Brandt","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Wang, Y., Jia, X., and Cong, B. (2024). Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1396031"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"108294","DOI":"10.1016\/j.pharmthera.2022.108294","article-title":"Comparative efficacy of different treatment modalities in the management of pediatric non-alcoholic fatty liver disease: A systematic review and network meta-analysis","volume":"240","author":"Theodoridis","year":"2022","journal-title":"Pharm. Ther."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1024\/0300-9831\/a000086","article-title":"Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver","volume":"81","author":"Akcam","year":"2011","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.clinthera.2008.06.012","article-title":"Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study","volume":"30","author":"Nobili","year":"2008","journal-title":"Clin. Ther."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.cgh.2018.05.023","article-title":"Evaluations of lifestyle, dietary, and pharmacologic treatments for pediatric nonalcoholic fatty liver disease: A systematic review","volume":"17","author":"Mann","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1007\/s00431-023-05169-9","article-title":"The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"182","author":"Gkiourtzis","year":"2023","journal-title":"Eur. J. Pediatr."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5604\/01.3001.0010.0284","article-title":"Meta-analysis of randomized controlled trials of pharmacologic agents in non-alcoholic steatohepatitis","volume":"16","author":"Said","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"102782","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: A narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_233","first-page":"e082446","article-title":"Protocol for a randomised, double-blinded, controlled trial of youth with childhood-onset obesity treated with semaglutide 2.4 mg\/week: The RESETTLE trial","volume":"14","author":"Byberg","year":"2024","journal-title":"BMJ"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0884533617713189","article-title":"Epidemiology of obesity and pharmacologic treatment options","volume":"32","author":"Shettar","year":"2017","journal-title":"Nutr. Clin. Pract."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes-state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: Causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/clinem\/dgab578","article-title":"The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD","volume":"107","author":"Cusi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Yan, Y., Gong, Y., Jiang, M., Gao, Y., Guo, S., Huo, J., Zhao, Z., and Li, C. (2023). Utilization of glucagon-like peptide-1 receptor agonists in children and adolescents in China: A real-world study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1170127"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2015.08.038","article-title":"Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis","volume":"64","author":"Armstrong","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/dom.15386","article-title":"Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial","volume":"26","author":"Qin","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/obr.12839","article-title":"Semaglutide as a promising antiobesity drug","volume":"20","author":"Christou","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamapediatrics.2013.1045","article-title":"The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: A randomized, placebo-controlled, clinical trial","volume":"167","author":"Kelly","year":"2013","journal-title":"JAMA Pediatr."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Choi, E., Ramirez Tovar, A., He, Z., Soler Rodriguez, D.M., Vos, M.B., Arora, S., and Fadoju, D. (2024). Glucagon-like Peptide-1 Receptor Agonists-A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD). Children, 11.","DOI":"10.3390\/children11030275"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1530\/EC-18-0499","article-title":"Reduced expression of thyroid hormone receptor \u03b2 in human nonalcoholic steatohepatitis","volume":"7","author":"Krause","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: A Molecular Insight","volume":"5","author":"Raza","year":"2021","journal-title":"Liver Res."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Dong, J.X., Jiang, L.L., Liu, Y.P., and Zheng, A.X. (2024). Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: A cross-sectional study from NHANES. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03556-6"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.1991","article-title":"Role of vitamin E in nonalcoholic fatty liver disease","volume":"71","author":"Nagashimada","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: A randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_253","first-page":"e72596","article-title":"Vitamin E and Non-alcoholic Fatty Liver Disease: Investigating the Evidence Through a Systematic Review","volume":"16","author":"Abera","year":"2024","journal-title":"Cureus"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Niu, Y., Zhang, Q., Wang, J., Li, Y., Wang, X., and Bao, Y. (2022). Vitamin E synthesis and response in plants. Front. Plant Sci., 13.","DOI":"10.3389\/fpls.2022.994058"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"El Hadi, H., Vettor, R., and Rossato, M. (2018). Vitamin E as a treatment for nonalcoholic fatty liver disease: Reality or myth?. Antioxidants, 7.","DOI":"10.3390\/antiox7010012"},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Panera, N., Braghini, M.R., Crudele, A., Smeriglio, A., Bianchi, M., Condorelli, A.G., Nobili, R., Conti, L.A., De Stefanis, C., and Lioci, G. (2022). Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis. Nutrients, 14.","DOI":"10.3390\/nu14183791"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"580474","DOI":"10.1155\/2015\/580474","article-title":"The role of vitamin D in diabetes and cardiovascular disease: An updated review of the literature","volume":"2015","author":"Papandreou","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1039\/D0FO01095B","article-title":"Vitamin D and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"11","author":"Guo","year":"2020","journal-title":"Food Funct."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Li, X., Liu, Y., Wang, J., Chen, X., Reichetzeder, C., Elitok, S., Kr\u00e4mer, B.K., Doebis, C., Huesker, K., and von Baehr, V. (2024). Vitamin D Is Associated with Lipid Metabolism: A Sex- and Age-Dependent Analysis of a Large Outpatient Cohort. Nutrients, 16.","DOI":"10.3390\/nu16223936"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Latic, N., and Erben, R.G. (2020). Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186483"},{"key":"ref_262","doi-asserted-by":"crossref","unstructured":"Szymczak-Pajor, I., and \u015aliwi\u0144ska, A. (2019). Analysis of association between vitamin D deficiency and insulin resistance. Nutrients, 11.","DOI":"10.3390\/nu11040794"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00394-024-03554-0","article-title":"Vitamin D supplementation alleviates high fat diet-induced metabolic associated fatty liver disease by inhibiting ferroptosis pathway","volume":"64","author":"Miao","year":"2024","journal-title":"Eur. J. Nutr."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Knuth, M.M., Xue, J., Elnagheeb, M., Gharaibeh, R.Z., Schoenrock, S.A., McRitchie, S., Brouwer, C., Sumner, S.J., Tarantino, L., and Valdar, W. (2024). Early life exposure to vitamin D deficiency impairs molecular mechanisms that regulate liver cholesterol biosynthesis, energy metabolism, inflammation, and detoxification. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1335855"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/ijpvm.IJPVM_499_17","article-title":"Effect of vitamin D on non-alcoholic fatty liver disease: A systematic review of randomized controlled clinical trials","volume":"10","author":"Hariri","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Park, C.Y., Shin, S., and Han, S.N. (2024). Multifaceted Roles of Vitamin D for Diabetes: From Immunomodulatory Functions to Metabolic Regulations. Nutrients, 16.","DOI":"10.3390\/nu16183185"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cbf.951","article-title":"Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3","volume":"20","author":"Maestro","year":"2002","journal-title":"Cell Biochem. Funct."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/js.2017-00472","article-title":"Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis","volume":"2","author":"Mirhosseini","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Sindhughosa, D.A., Wibawa, I.D.N., Mariadi, I.K., and Somayana, G. (2022). Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-11950-x"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/dc19-2265","article-title":"The effect of vitamin D supplementation on insulin sensitivity: A systematic review and meta-analysis","volume":"43","author":"Pramono","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00431-021-04243-4","article-title":"Vitamin D and nonalcoholic fatty liver disease in children: A randomized controlled clinical trial","volume":"181","author":"Abdelhai","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00394-017-1524-x","article-title":"Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis","volume":"57","author":"Oliveira","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/nutrit\/nuy031","article-title":"Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"76","author":"Loman","year":"2018","journal-title":"Nutr. Rev."},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Borka Balas, R., Meli\u021b, L.E., Lupu, A., Lupu, V.V., and M\u0103rginean, C.O. (2023). Prebiotics, Probiotics, and Synbiotics-A Research Hotspot for Pediatric Obesity. Microorganisms, 11.","DOI":"10.3390\/microorganisms11112651"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Castillo, V., Figueroa, F., Gonz\u00e1lez-Pizarro, K., Jopia, P., and Ibacache-Quiroga, C. (2021). Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. Foods, 10.","DOI":"10.3390\/foods10081719"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., and Lekic, N. (2019). Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020395"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13098-024-01561-z","article-title":"Understanding the complex function of gut microbiota: Its impact on the pathogenesis of obesity and beyond: A comprehensive review","volume":"16","author":"Yarahmadi","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Beisner, J., Filipe Rosa, L., Kaden-Volynets, V., Stolzer, I., G\u00fcnther, C., and Bischoff, S.C. (2021). Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.678360"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/hep.30206","article-title":"Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD","volume":"68","author":"Imai","year":"2018","journal-title":"Hepatology"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal microbiome and NAFLD: Molecular insights and therapeutic perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes. Surg."},{"key":"ref_284","unstructured":"Centers for Disease Control and Prevention (2021, December 17). Defining Childhood Weight Status BMI for Children and Teens, Available online: https:\/\/www.cdc.gov\/bmi\/child-teen-calculator\/bmi-categories.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/obesity\/basics\/childhood-defining.html."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"e20151766","DOI":"10.1542\/peds.2015-1766","article-title":"Physical examination findings among children and adolescents with obesity: An evidence-based review","volume":"137","author":"Armstrong","year":"2016","journal-title":"Pediatrics"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpeds.2016.08.101","article-title":"The benefit of sleeve gastrectomy in obese adolescents on nonalcoholic steatohepatitis and hepatic fibrosis","volume":"180","author":"Manco","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MPG.0000000000000715","article-title":"Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis: ESPGHAN Hepatology Committee Position Statement","volume":"60","author":"Manco","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.soard.2024.08.040","article-title":"Outcomes of adolescent bariatric surgery: Liver disease","volume":"21","author":"Brichta","year":"2025","journal-title":"Surg. Obes. Relat. Dis."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/5\/287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:20:27Z","timestamp":1760030427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/5\/287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":288,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["metabo15050287"],"URL":"https:\/\/doi.org\/10.3390\/metabo15050287","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}